Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07150923 · ClinicalTrials.gov registry record · NA
Supraglottic Airway for Resuscitation Trial
A NA study of Infant, Newborn and Implementation Research, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- NA
- Development phase
- 36,503
- Enrollment target
- 20
- Study locations
NCT07150923: Recruiting NA study of Infant, Newborn and Implementation Research, sponsored by Children's Hospital of Philadelphia.
NCT07150923 is a NA study of Infant, Newborn and Implementation Research that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 36,503 participants, below the 225,671-participant average among 14 other Infant, Newborn trials with a reported enrollment target (84% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07150923, a NA study of Infant, Newborn and Implementation Research, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- NA
- Development phase
- 36,503 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.
Primary Outcome
Proportion of eligible patients treated with SA as an early rescue device. Excludes SA after intubation attempt.
Conditions Studied
Interventions
- OTHER Enhanced Standard of Care ("Enhanced")
- OTHER Enhanced Standard of Care ("Enhanced-Plus")
Study Locations (20)
California
- Sharp Chula Vista Medical Center - Chula Vista
- Sharp Grossmont Hospital - La Mesa
- Cedars-Sinai Medical Center - Los Angeles
- Rady Children's NICU at Rancho Springs Medical Center - Murrieta
- Lucile Packard Children's Hospital - Palo Alto
- Jacobs Medical Center at University of California San Diego Health - San Diego
- Sharp Mary Birch Hospital for Women & Newborns - San Diego
New York
- South Shore University Hospital - Bay Shore
- Lenox Hill Hospital - New York
- Cohen Children's Medical Center - Queens
Maine
- MaineHealth Mid Coast Hospital - Brunswick
- MaineHealth Maine Medical Center - Portland
Alabama
- University of Alabama at Birmingham - Birmingham
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Delaware
- ChristianaCare - Newark
Illinois
- St. John's Children's Hospital - Springfield
Indiana
- Riley Hospital for Children - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36,503 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2029-09 |
| Phase | NA |
What NCT07150923 shows while recruiting
NCT07150923 is an interventional study that assigns participants to a tested intervention. Its 36,503 participants enrollment target places it among the larger protocols in the corpus, below the 225,671-participant average among 14 other Infant, Newborn trials with a reported enrollment target (84% lower).
The record links to 7 conditions, with Infant, Newborn appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Standard of Care ("Enhanced") is the first listed.
NCT07150923 names 20 study sites across 11 states, led by California, New York, Maine.
Frequently Asked Questions
What is clinical trial NCT07150923 about?
NCT07150923 is a clinical study titled "Supraglottic Airway for Resuscitation Trial". This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.
What is the current status of trial NCT07150923?
This trial is currently recruiting. It is a NA study. The enrollment target is 36,503 participants. The study started on 2026-01-01. Estimated completion is 2029-09.
What conditions does trial NCT07150923 study?
This clinical trial studies the following conditions: Infant, Newborn, Implementation Research, Neonatal Resuscitation, Supraglottic Airway, Delivery Room Resuscitation.
What interventions are being tested in trial NCT07150923?
The interventions under investigation include: Enhanced Standard of Care ("Enhanced") (OTHER), Enhanced Standard of Care ("Enhanced-Plus") (OTHER).
Who is sponsoring clinical trial NCT07150923?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07150923 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Delaware, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant, Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07150923's enrollment target sits among peer trials
36,503 4th of 14 higher than 11 of 14 other Infant, Newborn trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infant, Newborn trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children
RECRUITING · NA
-
Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates
COMPLETED · NA
-
Generic Database of Very Low Birth Weight Infants
RECRUITING
-
Delivery Room Intervention and Evaluation Network
RECRUITING
-
Follow-up Visit of High Risk Infants
RECRUITING
-
Cerebral Function Monitoring in Premature Infants
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT05796505 · 37,122 participants · NA
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI